Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA prospective trial of midwest breast cancer patients: A p53 gene mutation is the most important predictor of adverse outcome.AuthorsBlaszyk, Hagen; Hartmann, Arndt; Cunningham, Julie M.; Schaid, Daniel; Wold, Lester E.; Kovach, John S.; Sommer, Steve S.PublicationInternational Journal of Cancer, 2000, Vol 89, Issue 1, p32ISSN0020-7136Publication typeArticleDOI10.1002/(SICI)1097-0215(20000120)89:1<32::AID-IJC6>3.0.CO;2-G